Q32 Bio Inc. (QTTB)
USD 3.13
(-8.75%)
USD 3.13
(-8.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -96.23 Million | -10.95 Million | -32.97 Million | -94.33 Million | -91.35 Million | -42.56 Million |
| Net Income | -112.96 Million | -42.8 Million | -37.56 Million | -128.69 Million | -103.91 Million | -55.57 Million |
| Depreciation & Amortization | 578 Thousand | 370 Thousand | 47 Thousand | 8.9 Million | 6.31 Million | 1.28 Million |
| Deferred income taxes | - | 2.42 Million | - | - | - | - |
| Stock-based compensation | - | 1.23 Million | 753 Thousand | - | - | - |
| Change in working capital | -7.2 Million | 26.94 Million | 3.68 Million | 11.52 Million | 463 Thousand | 10.56 Million |
| Other non-cash items | 22.42 Million | 876 Thousand | 102 Thousand | 29.28 Million | 22.86 Million | -644 Thousand |
| Investing Cash Flow | 101.32 Million | -2.46 Million | -157 Thousand | 204.89 Million | -51.79 Million | -121.78 Million |
| Investments in PPE | -228 Thousand | -2.48 Million | -157 Thousand | -3.73 Million | -21.83 Million | -24.93 Million |
| Acquisitions | 554 Thousand | 130 Million | - | - | - | - |
| Investment purchases | -73.24 Million | -157.46 Million | -97.39 Million | -19.99 Million | -286.39 Million | -245.32 Million |
| Sales/Maturities of investments | 174.24 Million | 65.46 Million | 49 Million | 228.62 Million | 256.42 Million | 148.48 Million |
| Other Investing Activities | - | -37.98 Million | 48.39 Million | - | - | - |
| Financing Cash Flow | 184 Thousand | 30.06 Million | 20.1 Million | 53.09 Million | 158.21 Million | 150.99 Million |
| Debt repayment | - | -30 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 184 Thousand | 69 Thousand | 115 Thousand | 53.09 Million | 158.21 Million | 150.99 Million |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.08 Million | -1.24 Million | 1.09 Million | 2.45 Million | -4.45 Million | 4.38 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -9.29 Million | 28.18 Million | 2.58 Million | 9.06 Million | 4.91 Million | 6.18 Million |
| Cash at beginning of period | 33.98 Million | 32.89 Million | 45.92 Million | 53.77 Million | 38.22 Million | 51.57 Million |
| Cash at end of period | 39.26 Million | 49.54 Million | 32.98 Million | 217.43 Million | 53.77 Million | 38.22 Million |
| Capital Expenditure | -228 Thousand | -2.48 Million | -157 Thousand | -3.73 Million | -21.83 Million | -24.93 Million |
| Effect of forex changes on cash | - | - | 90 Thousand | - | 498 Thousand | - |
| Net cash flow / Change in cash | 5.28 Million | 16.64 Million | -12.94 Million | 163.65 Million | 15.55 Million | -13.35 Million |
| Free Cash Flow | -96.45 Million | -13.44 Million | -33.13 Million | -98.06 Million | -113.19 Million | -67.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.97 Million | 1.02 Million | -16.11 Million | -112.96 Million | -32.95 Million | -35.04 Million |
| Depreciation & Amortization | 121 Thousand | 123 Thousand | - | 578 Thousand | 136 Thousand | 564 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.33 Million | 417 Thousand | - | - | 300 Thousand | 310 Thousand |
| Change in working capital | -6.75 Million | -576 Thousand | -11.54 Million | -7.2 Million | 3.13 Million | 3.27 Million |
| Other non-cash items | -1.18 Million | 170 Thousand | 10.65 Million | 22.42 Million | 606 Thousand | 8.91 Million |
| Investing Cash Flow | 9.88 Million | 97 Thousand | 31.71 Million | 101.32 Million | -22.76 Million | 61 Million |
| Investments in PPE | -15 Thousand | - | - | -228 Thousand | -1000.00 | 1000.00 |
| Acquisitions | - | - | 216 Thousand | 554 Thousand | 338 Thousand | - |
| Investment purchases | - | - | - | -73.24 Million | -47.95 Million | 1000.00 |
| Sales/Maturities of investments | 9.9 Million | 97 Thousand | 31.5 Million | 174.24 Million | 24.85 Million | 61 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -5.52 Million | 99.34 Million | 14 Thousand | 184 Thousand | 18 Thousand | 2000.00 |
| Debt repayment | - | -7 Million | - | - | -300 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 42 Million | 14 Thousand | 184 Thousand | 18 Thousand | 2000.00 |
| Other Financing Activities | -5.9 Million | 50.34 Million | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.47 Million | 928 Thousand | -4.56 Million | 2.08 Million | 4.41 Million | -242 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -4.28 Million | - | -6.97 Million | -9.29 Million | -1.27 Million | 3.51 Million |
| Cash at beginning of period | 116.15 Million | 31.26 Million | 29.11 Million | 33.98 Million | 76.79 Million | 39.45 Million |
| Cash at end of period | 98.3 Million | 116.15 Million | 39.26 Million | 39.26 Million | 29.11 Million | 76.79 Million |
| Capital Expenditure | -15 Thousand | - | - | -228 Thousand | -1000.00 | 1000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.84 Million | 84.89 Million | 10.15 Million | 5.28 Million | -47.68 Million | 37.34 Million |
| Free Cash Flow | -22.22 Million | -14.55 Million | -21.57 Million | -96.45 Million | -24.94 Million | -23.65 Million |
GLOP-PA
SAVE
DIB
ASAHIINDIA
NAN
300534